0001666071-20-000307.txt : 20201217 0001666071-20-000307.hdr.sgml : 20201217 20201217165849 ACCESSION NUMBER: 0001666071-20-000307 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201215 FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOMERS KIRK CENTRAL INDEX KEY: 0001204015 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 201396770 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wf-form4_160824216401396.xml FORM 4 X0306 4 2020-12-15 0 0001666071 Cardlytics, Inc. CDLX 0001204015 SOMERS KIRK C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 0 1 0 0 Chief Legal & Privacy Officer Common Stock 2020-12-15 4 S 0 2169 128.81 D 79165 D Common Stock 2020-12-15 4 S 0 5431 129.95 D 73734 D Common Stock 2020-12-15 4 S 0 5961 130.80 D 67773 D Common Stock 2020-12-15 4 S 0 1601 131.78 D 66172 D Common Stock 2020-12-15 4 S 0 3000 132.85 D 63172 D Common Stock 2020-12-15 4 S 0 203 133.70 D 62969 D Common Stock 2020-12-15 4 S 0 2960 135 D 60009 D Common Stock 2020-12-15 4 S 0 300 136 D 59709 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $128.30 to $129.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7), (8), (9) and (10) to this Form 4. Includes 175 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $129.33 to $130.32, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $130.33 to $131.26, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $131.36 to $132.18, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $132.36 to $133.35, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $133.45 to $133.95, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $134.50 to $135.43, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $135.99 to $136.00, inclusive. /s/ Kirk L. Somers 2020-12-17